S&S Endo Inc provides bone-health evaluation and osteoporosis treatment in Miami for patients with low bone density, osteopenia, osteoporosis, fragility fractures, and hormonal conditions that can weaken bones. Care focuses on understanding fracture risk and choosing treatment only when it is appropriate for the individual patient.
Osteopenia means bone density is lower than expected but not low enough to meet osteoporosis criteria. Osteoporosis means bones are fragile enough that fracture risk is higher. Both require a careful look at age, fracture history, DEXA results, medications, and hormonal factors.
A DEXA scan measures bone density and reports T-scores. A T-score compares bone density with a young healthy reference range. FRAX can estimate fracture risk using clinical factors and sometimes bone-density results. Lab testing may look for vitamin D deficiency, calcium problems, thyroid or parathyroid disease, and other causes of secondary osteoporosis.
An endocrinology visit is helpful after a low DEXA score, osteopenia with risk factors, osteoporosis, a fragility fracture, suspected parathyroid or thyroid-related bone loss, or uncertainty about medication choices.
S&S Endo connects bone density results with endocrine causes of bone loss, menopause-related risk, thyroid and parathyroid health, medication safety, and long-term fracture prevention.
Board-certified in Internal Medicine; Endocrinology, Diabetes & Metabolism; and Obesity Medicine. Last reviewed/updated: 2026-09-22
Osteopenia is lower-than-normal bone density that is not severe enough to be osteoporosis. Osteoporosis is more advanced bone loss with higher fracture risk.
DEXA screening is commonly recommended for women 65 and older, men 70 and older, and younger adults with risk factors such as fragility fracture, steroid use, or hormonal causes of bone loss.
A T-score compares your bone density with a young healthy reference range. Lower scores suggest lower bone density and may guide whether monitoring or medication is appropriate.
Yes. Lower estrogen after menopause can speed bone loss and increase fracture risk, especially when combined with other risk factors.
Yes. Treatment may include nutrition, calcium and vitamin D optimization, exercise, fall prevention, and medication when fracture risk supports it.
The timing of repeat DEXA testing depends on your baseline results, risk factors, and treatment plan. Many patients are rechecked every one to two years when monitoring is needed.
Contact: (305) 209-2191 | 7392 NW 35th Terrace, Suite 306, Miami, FL 33122